Arthritis psoriatica: vizsgálatok itt: Egyesült Királyság
11 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Bristol, Liverpool, London, Oxford, Sheffield
- Életkor
- 1 év to 18 év
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Sheffield, Stoke-on-Trent
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - No phaseTaking peopleTreatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor
- Where
- Bath
- Életkor
- 18 év and over
- People
- 700
- Run by
- Adelphi Real World
See details and how to joinNCT07166315 - 3. fázisTaking peopleAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
- Where
- Bristol, Manchester, Nottingham, Stoke-on-Trent
- Életkor
- 2 év to 18 év
- People
- 40 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00 - 3. fázisTaking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Birmingham, Liverpool, Nottingham, Oxford
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - 3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Bristol, Liverpool, Sheffield
- Életkor
- 5 év to 17 év
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - No phaseNot yet taking people in Egyesült KirályságA Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis
- Where
- Bath
- Életkor
- 18 év and over
- People
- 400
- Run by
- Royal United Hospitals Bath NHS Foundation Trust
See details and how to joinNCT07417995 - No phaseTaking peopleCombination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- Where
- Birmingham, Coventry, Glasgow, Newcastle upon Tyne
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07443956 - No phaseNot yet taking people in Egyesült KirályságRewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis
- Where
- Glasgow
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07403890 - No phaseTaking peopleEvaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
- Where
- Glasgow
- Életkor
- 18 év to 74 év
- People
- 50
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT06786936 - No phaseTaking peopleHIPPOCRATES Prospective Observational Study
- Where
- Oxford
- Életkor
- 18 év and over
- People
- 25 000
- Run by
- University of Oxford
See details and how to joinNCT05858528